{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:53:14Z","timestamp":1787727194062,"version":"build-2784847793"},"reference-count":30,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2021.2389","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T08:55:41Z","timestamp":1630918541000},"source":"Crossref","is-referenced-by-count":7,"title":["Mammary analogue secretory carcinoma of a salivary gland of the hard palate with contralateral cervical lymph node metastases: A case report"],"prefix":"10.3892","volume":"15","author":[{"given":"Anton","family":"Straub","sequence":"first","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Linz","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Strobel","sequence":"additional","affiliation":[{"name":"Institute of Pathology of The University of Wuerzburg, D\u201197080 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hohm","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"M\u00fcller\u2011richter","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"K\u00fcbler","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Brands","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial and Plastic Surgery of The University of Wuerzburg, D\u201197070 Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,6]]},"reference":[{"key":"key20211013103159_b1-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: A hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20211013103159_b2-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12105-017-0795-0","article-title":"Update from the 4th Edition of the World Health Organization classification of head and neck tumours: Tumors of the salivary gland","volume":"11","author":"Seethala","year":"2017","journal-title":"Head Neck Pathol"},{"key":"key20211013103159_b3-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1097\/PAT.0000000000000322","article-title":"Mammary analogue secretory carcinoma: An evaluation of its clinicopathological and genetic characteristics","volume":"47","author":"Luk","year":"2015","journal-title":"Pathology"},{"key":"key20211013103159_b4-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00428-014-1701-8","article-title":"Mammary analogue secretory carcinoma of salivary glands: A new entity associated with ETV6 gene rearrangement","volume":"466","author":"Majewska","year":"2015","journal-title":"Virchows Arch"},{"issue":"7416302","key":"key20211013103159_b5-MCO-0-0-02389","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7416302","article-title":"Mammary analogue secretory carcinoma of the palate: Case report and review of the literature","volume":"2019","author":"Boliere","year":"2019","journal-title":"Case Rep Dent"},{"key":"key20211013103159_b6-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"997","DOI":"10.5858\/arpa.2015-0075-RS","article-title":"Mammary analogue secretory carcinoma","volume":"140","author":"Stevens","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"key20211013103159_b7-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12105-014-0557-1","article-title":"Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma","volume":"9","author":"Shah","year":"2015","journal-title":"Head Neck Pathol"},{"key":"key20211013103159_b8-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.humpath.2013.06.010","article-title":"Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma","volume":"44","author":"Patel","year":"2013","journal-title":"Hum Pathol"},{"key":"key20211013103159_b9-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/hed.24755","article-title":"Systematic review of mammary analog secretory carcinoma of salivary glands at 7 years after description","volume":"39","author":"Khalele","year":"2017","journal-title":"Head Neck"},{"key":"key20211013103159_b10-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1007\/s12105-013-0455-y","article-title":"Mammary analogue secretory carcinoma of salivary gland origin: An update and expanded morphologic and immunohistochemical spectrum of recently described entity","volume":"1 (Suppl 1)","author":"Skalova","year":"2013","journal-title":"Head Neck Pathol 7"},{"issue":"e1003552","key":"key20211013103159_b11-MCO-0-0-02389","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003552","article-title":"NTRK3 is a potential tumor suppressor gene commonly inactivated by epigenetic mechanisms in colorectal cancer","volume":"9","author":"Luo","year":"2013","journal-title":"PLoS Genet"},{"key":"key20211013103159_b12-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.oraloncology.2018.04.022","article-title":"Clinicopathological characteristics and outcome of 31 patients with ETV6-NTRK3 fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands","volume":"82","author":"Boon","year":"2018","journal-title":"Oral Oncol"},{"key":"key20211013103159_b13-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/PAS.0000000000000088","article-title":"Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: Report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, \u03b2-catenin, EGFR, and CCND1 genes","volume":"38","author":"Sk\u00e1lov\u00e1","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20211013103159_b14-MCO-0-0-02389","author":"Brierley"},{"key":"key20211013103159_b15-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2559.2012.04232.x","article-title":"Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands","volume":"61","author":"Chiosea","year":"2012","journal-title":"Histopathology"},{"key":"key20211013103159_b16-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/PAS.0b013e318231542a","article-title":"Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: Expanded morphologic and immunohistochemical spectrum of a recently described entity","volume":"36","author":"Connor","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key20211013103159_b17-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1002\/lary.24254","article-title":"Mammary analogue secretory carcinoma: Update on a new diagnosis of salivary gland malignancy","volume":"124","author":"Sethi","year":"2014","journal-title":"Laryngoscope"},{"key":"key20211013103159_b18-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ijom.2019.01.027","article-title":"Locally advanced mammary analogue secretory carcinoma of the parotid gland","volume":"48","author":"Tokuzen","year":"2019","journal-title":"Int J Oral Maxillofac Surg"},{"key":"key20211013103159_b19-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/s1368-8375(01)00092-6","article-title":"Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology","volume":"38","author":"Slootweg","year":"2002","journal-title":"Oral Oncol"},{"key":"key20211013103159_b20-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1001\/archotol.1994.01880310005001","article-title":"Use of decision analysis in planning a management strategy for the stage N0 neck","volume":"120","author":"Weiss","year":"1994","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key20211013103159_b21-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/s0002-9610(05)80554-9","article-title":"The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity","volume":"66","author":"Shah","year":"1990","journal-title":"Cancer"},{"key":"key20211013103159_b22-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-3-642-84971-8_7","article-title":"Radical neck dissection versus conservative neck dissection for squamous cell carcinoma of the oral cavity","volume":"134","author":"Bier","year":"1994","journal-title":"Recent Results Cancer Res"},{"key":"key20211013103159_b23-MCO-0-0-02389","author":"Wolff"},{"key":"key20211013103159_b24-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"123","DOI":"10.18926\/AMO\/58270","article-title":"The diagnostic capacity of pre-treatment 18F-FDG PET\/CT for predicting the extranodular spread of lymph node metastases in patients with oral squamous cell carcinoma","volume":"74","author":"Fukuhara","year":"2020","journal-title":"Acta Med Okayama"},{"key":"key20211013103159_b25-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.clon.2011.03.008","article-title":"Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma","volume":"23","author":"Loo","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20211013103159_b26-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00405-019-05282-2","article-title":"Contemporary treatment patterns and outcomes of salivary gland carcinoma: A national cancer database review","volume":"276","author":"Ferrell","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"e000023","key":"key20211013103159_b27-MCO-0-0-02389","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO Open"},{"key":"key20211013103159_b28-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two Phase I Trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov"},{"key":"key20211013103159_b29-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","article-title":"Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"key20211013103159_b30-MCO-0-0-02389","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T08:54:08Z","timestamp":1634115248000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2021.2389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,6]]},"references-count":30,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,6]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2021.2389","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,6]]},"article-number":"226"}}